FOXO1 and autism spectrum disorder: These findings suggest that Rg1 alleviates VPA‐induced behavioral and neuropathological abnormalities, potentially via Sirt2/Foxo1‐mediated regulation of neuroinflammation and oxidative stress, and may represent a promising therapeutic strategy for autism spectrum disorder.